206 High St, Suite 2
PO Box 726
New Windsor, MD 21776
In addition to successful, client-based product development, ImmTech develops and markets life science products to global academic and industrial customers. These products include kits and reagents that incorporate ImmunoMagnetic Separation (IMS) technology, improved detection methodologies, and unique, application-specific reagents that enhance test performance.
- Development and sales of a sensitive and specific enzyme-linked immunosorbent assay (ELISA) for the detection of Influenza A nucleoprotein antigen in human and veterinary samples.
- Photometric and chemiluminescent formats
- Nucleoprotein antigen calibration kit to assist in quantitation
- Development and sales of a sensitive and specific enzyme-linked immunosorbent assay (ELISA) for the detection of Influenza A nucleoprotein antibody in human and veterinary samples.
- Nucleoprotein specific
- Non-species specific
- Development and sales of analyte-specific, antibody-coated paramagnetic beads for ImmunoMagnetic (IMS) applications.
- Anti-E. coli spp.
- Anti-Enterococci (Group D Streptococci)
- Development and optimization of application-specific diluents and buffers for enhanced assay performance.
- IMS Assay Buffer
- Immunofluorescence Assay (IFA) Diluent
- Production and sales of products for the detection of Fatty Acid Synthase (FAS) in serum and tissues.
- FAS-detect ELISA
- FAS-detect IHC
- Development and manufacture of sensitive and stable enzyme substrates (Horseradish Peroxidase, Alkaline Phosphatase) for use in ELISA, Western Blotting, and Immunohistochemistry. One patent issued, one patent pending.
- Development and optimization of a rapid, nonisotopic assay for measuring cell-mediated (T-cell) immunity using whole blood (bioluminescent readout based on ATP measurement). Patent issued, FDA-cleared.
- Qualitative, quantitative, and functional immuoassays for the detection of human-mouse chimeric antibody, including nonisotopic antibody-dependent cellular cytotoxicity (ADCC) assay.
- Sensitive ELISA for the measurement of induced fibrinogen (acute phase protein) synthesis and secretion secondary to cell activation.
- Development and optimization of sensitive hybridization assays for the in situ detection of messenger RNA.